Antireflux metal stent for biliary obstruction: Any benefits?
- 6 April 2020
- journal article
- review article
- Published by Wiley in Digestive Endoscopy
- Vol. 33 (3) , 310-320
Abstract
Endoscopic retrograde cholangiopancreatography with stent placement has been utilized as standard palliative management of distal malignant biliary obstruction (MBO). Compared to plastic stents, metal stents can provide longer‐term relief of symptoms. When a large‐bore metal stent is placed across the ampulla, patients are predisposed to the risk of cholangitis or stent dysfunction due to reflux of duodenal contents. To mitigate the risk of adverse events associated with the duodenobiliary reflux, efforts have been directed to development of antireflux metal stents (ARMSs). The antireflux property has been introduced through adding of an antireflux valve to the duodenal stent end. Evidence from clinical studies indicates that ARMSs may not only reduce the risk of ascending cholangitis during follow‐up but also prolong stent patency time. However, the results of clinical studies testing ARMSs are inconsistent owing to heterogeneous designs of antireflux valves and stent bodies. Metal stents are increasingly indicated for benign biliary strictures and MBO in the setting of neoadjuvant chemotherapy, and therefore, research is warranted to evaluate ARMSs for those indications. Given that endoscopic ultrasound (EUS)‐guided transmural biliary drainage has gained popularity, the optimal timing of placing an ARMS in relation to EUS‐guided and percutaneous drainage should be investigated. Development and evaluation of ARMSs require an integrative approach utilizing phantom and animal models, measurements of stent mechanical properties, and in vivo functional study after stent placement. In this review article, we summarize updated evidence on ARMSs for MBO and discuss issues that should be addressed in future studies.Keywords
Funding Information
- Japanese Foundation for Research and Promotion of Endoscopy
This publication has 117 references indexed in Scilit:
- Functional Self-Expandable Metal Stents in Biliary ObstructionClinical Endoscopy, 2013
- Duodenal metal stent placement is a risk factor for biliary metal stent dysfunction: an analysis using a time-dependent covariateSurgical Endoscopy, 2012
- One- and two-step self-expandable metal stent placement for distal malignant biliary obstruction: a propensity analysisJournal of Gastroenterology, 2012
- Risk factors for pancreatitis following transpapillary self-expandable metal stent placementSurgical Endoscopy, 2011
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstructionGastrointestinal Endoscopy, 2010
- Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter studyGastrointestinal Endoscopy, 2010
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract CancerNew England Journal of Medicine, 2010
- Placement of a metallic stent across the main duodenal papilla may predispose to cholangitisGastrointestinal Endoscopy, 2006
- Efficacy and safety of the covered Wallstent in patients with distal malignant biliary obstructionGastrointestinal Endoscopy, 2005